Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for
Yahoo Finance · 1 day ago
Open | 270.00 |
High | 279.67 |
Low | 268.33 |
Mkt Cap | 7.87B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 269.75 |
52 Wk. Low | 261.59 |
52 Wk. High | 473.50 |
Related stocks
Bio Technology Firm
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 681.18M | 6.70% ▼ |
Net Income | 349.71M | 57.80% ▼ |
Diluted EPS | 3.10 | 56.30% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | $2.15 | - |
Q4 2023 | $2.82 | $3.10 |
Q3 2023 | $2.78 | $2.33 |
S&P FuturesES=F | 5,069.00+22.50 (+0.45%) |
Dow FuturesYM=F | 38,203.00+134.00 (+0.35%) |
Nasdaq FuturesNQ=F | 17,535.25+97.00 (+0.56%) |
Carvana Co.CVNA | 87.09+5.03% |
164.11-1.05% | |
56.31-16.84% |